Skip to content
The Policy VaultThe Policy Vault

WegovyCigna

Weight Loss in a Pediatric Patient with Obesity

Initial criteria

  • Patient age ≥ 12 years and < 18 years
  • Patient has engaged in a trial of behavioral modification and dietary restriction for at least 3 months
  • At baseline, patient had a BMI ≥ 95th percentile for age and sex
  • The medication will be used concomitantly with behavioral modification and a reduced-calorie diet

Reauthorization criteria

  • Patient age ≥ 12 years and < 18 years
  • At baseline, patient had a BMI ≥ 95th percentile for age and sex
  • Patient has had a reduction in BMI of ≥ 1% from baseline
  • The medication will be used concomitantly with behavioral modification and a reduced-calorie diet

Approval duration

initial 7 months, reauth 1 year